Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
5 things to know before the stock market opens on Tuesday
12:08pm, Tuesday, 04'th Aug 2020
U.S. stock futures traded slightly lower on Tuesday as Wall Street took a breather following sharp gains in the previous session.
Abiomed heart pump gets second FDA emergency use nod for COVID-19 patients
12:05pm, Tuesday, 04'th Aug 2020
Medical device maker Abiomed Inc said on Tuesday the U.S. Food and Drug Administration granted its left-sided heart pumps emergency use authorization to help patients suffering from COVID-19-related h
Global deaths surpass 700,000; Vietnam reports further rise of infections
11:51am, Tuesday, 04'th Aug 2020
The coronavirus has infected more than 18.5 million people around the world as of Wednesday, killing at least 701,085 people.
Abiomed's stock rises on second COVID-19-related EUA for heart pump
11:48am, Tuesday, 04'th Aug 2020
Shares of Abiomed Inc. undefined rallied 2.0% in premarket trading on Tuesday after the company said its Impella heart pump had received an emergency use...
Abiomed's stock rises on second COVID-19-related EUA for heart pump
11:48am, Tuesday, 04'th Aug 2020
Shares of Abiomed Inc. rallied 2.0% in premarket trading on Tuesday after the company said its Impella heart pump had received an emergency use authorization from the Food and Drug Administration as
FDA approves Abiomed heart pump to treat coronavirus patients
11:03am, Tuesday, 04'th Aug 2020
The Food and Drug Administration has approved the emergency use of Abiomed's Impella heart pump for Covid-19 patients with heart failure.
FDA Issues Emergency Use Authorization for Impella Heart Pumps to Provide Unloading Therapy to COVID-19 Patients
11:00am, Tuesday, 04'th Aug 2020
The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading and support to COVID-19 pa
Zurcher Kantonalbank Zurich Cantonalbank Reduces Position in ABIOMED, Inc. (NASDAQ:ABMD)
08:12am, Tuesday, 04'th Aug 2020
Zurcher Kantonalbank Zurich Cantonalbank cut its stake in shares of ABIOMED, Inc. (NASDAQ:ABMD) by 30.2% during the second quarter, according to its most recent Form 13F filing with the Securities and
Janney Montgomery Scott LLC Cuts Stake in ABIOMED, Inc. (NASDAQ:ABMD)
06:20am, Tuesday, 04'th Aug 2020
Janney Montgomery Scott LLC cut its stake in shares of ABIOMED, Inc. (NASDAQ:ABMD) by 3.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange
FDA Issues Emergency Use Authorization for Impella Heart Pumps to Provide Unloading Therapy to COVID-19 Patients
12:00am, Tuesday, 04'th Aug 2020
The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide lef
Große Multicenter-Studie in Japan findet hohe Überlebensraten bei Verwendung von Impella Herzpumpen
12:00am, Monday, 03'rd Aug 2020
Eine dreijährige, von Prüfern geleitete prospektive Studie an japanischen Patienten mit einer Impella Herzpumpe stellte beim Einsatz von Impella bei P
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
How Much Is Abiomed, Inc. (NASDAQ:ABMD) Paying Its CEO?
12:02pm, Friday, 31'st Jul 2020
This article will reflect on the compensation paid to Mike Minogue who has served as CEO of Abiomed, Inc...
Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump
12:00pm, Thursday, 30'th Jul 2020
A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump finds use of Impella is associated with a 77% survival rate at 30 days in AMI cardiogenic shoc
